The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Dry Eye Medication Market By The End Of 2030?
The dry eye medication market size has experienced robust growth in recent years. Projections indicate a rise from $12.13 billion in 2025 to $13.34 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. Historically, this expansion can be linked to factors such as an aging population, increased screen time, the prevalence of autoimmune disorders, inadequate awareness of dry eye treatments, and a scarcity of advanced formulations.
The dry eye medication market is expected to experience substantial growth in the next few years. It is projected to reach $20.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This expansion during the forecast period can be attributed to technological advancements in eye care, the widening scope of teleophthalmology, an increasing preference for home-based therapies, rising healthcare expenditure, and the introduction of multi-action eye care products. Significant trends anticipated in the forecast period include a greater adoption of combination eye drops, an increase in over-the-counter dry eye products, the development of lipid-based eye therapies, a rise in prescription eye drop usage, and the expansion of online pharmacy distribution channels.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3807&type=smp
What Drivers Are Shaping The Future Growth Of The Dry Eye Medication Market?
The escalating volume of ocular surgery procedures is anticipated to drive the expansion of the dry eye medication market. Ocular surgery involves a surgical discipline focused on the diagnosis, treatment, and management through surgery of various eye conditions and diseases. In eye surgery, dry eye medication is vital for keeping the eye’s surface lubricated and comfortable, thereby assisting in smoother surgical processes and better post-operative recovery. For example, in July 2025, according to the GOV.UK, a UK-based intergovernmental organization, the financial year ending 2024 saw 581,369 hospital admissions for cataract surgery in England, at a rate of 5,160 (5,144 to 5,176) per 100,000 population. This figure was considerably higher than the previous financial year’s rate of 4,679 (4,663 to 4,694). Thus, the increasing number of ocular surgery procedures is propelling the growth of the dry eye medication market.
Which Segment Classifications Shape The Dry Eye Medication Market?
The dry eye medication market covered in this report is segmented –
1) By Type Of Product: Aqueous, Evaporative, Aqueous and Evaporative
2) By Delivery System: Liquid, Gel, Ointment, Other Delivery System
3) By Prescription Type: OTC Drugs, Prescription Drugs
4) By End-User: Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Aqueous: Artificial Tears, Prescription Eye Drops, Ophthalmic Solutions
2) By Evaporative: Punctal Plugs, Lipid-Based Eye Drops, Eye Ointments
3) By Aqueous and Evaporative: Combination Eye Drops, Multi-Action Eye Care Products
How Are Trends Impacting The Dry Eye Medication Market?
Companies operating in the drugs for dry eye market are increasingly concentrating on launching single-ingredient prescription eye drops, such as Miebo, to maximize their revenue within the market. Miebo is a prescription eye drop designed to treat the signs and symptoms associated with dry eye disease. For example, in September 2023, Bausch + Lomb, a US-based eye health firm, introduced Miebo in the United States for managing the signs and symptoms of dry eye disease. Miebo is unique as the first and only prescription eye drop that directly targets tear evaporation, recognized as the primary cause of dry eye disease. This single-ingredient prescription eye drop, Miebo, is formulated without water, preservatives, or steroids, ensuring it spreads swiftly and comfortably to reduce tear evaporation on the ocular surface.
Which Companies Are Expanding Their Footprint In The Dry Eye Medication Market?
Major companies operating in the dry eye medication market are Allergan plc, Alcon Inc., Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., OASIS Medical Inc., VISUfarma B.V., Sun Pharmaceutical Industries Limited, Bayer AG, Pfizer, Johnson & Johnson, Daiichi Sankyo, Zhaoke Ophthalmology Pharmaceutical, Implandata ophthalmic products GmbH, The Geuder Group, Novamedika, Aflofarm Farmacja Polska, VUAB Pharma Inc., Alimera Sciences, Eyegate, Neurotech, Opthotech, Eyepoint Pharmaceuticals, ReGenTree LLC, Regenerx Biopharmaceuticals Inc, Shire, Gama Vision, Biolab Pharma, Novaliq GmbH, Horus Pharma, Prestige Consumer Healthcare Inc., Azura Ophthamics Ltd, Similasan, Hoya Corporation, Adcock Ingram
Read the full dry eye medication market report here:
https://www.thebusinessresearchcompany.com/report/dry-eye-medication-global-market-report
Which Geographic Regions Are Influencing Demand In The Dry Eye Medication Market?
North America was the largest region in the market in 2025. Middle East is expected to be the fastest-growing region in the global dry eye medication market share during the forecast period. The regions covered in the dry eye medication market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Dry Eye Medication Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3807&type=smp
Browse Through More Reports Similar to the Global Dry Eye Medication Market 2026, By The Business Research Company
Dry Eye Medication Market 2026
https://www.thebusinessresearchcompany.com/report/dry-eye-medication-market
Dry Eye Products Market Report 2026
https://www.thebusinessresearchcompany.com/report/dry-eye-products-global-market-report
Dry Eye Syndrome Market Report 2026
https://www.thebusinessresearchcompany.com/report/dry-eye-syndrome-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model